VenatoRx Pharmaceuticals is a disease-focused pharmaceutical company dedicated to the discovery and development of novel anti-infective agents.

Our Goal is to identify and progress into clinical development best-in-class small molecules able to address the growing concern of today’s and tomorrow’s resistant bacterial infections.

The company was founded and is managed by experienced and accomplished pharmaceutical veterans with >75 years experience spanning Big Pharma to Start-up environments.